digitalmarket

The demand for donated blood is rising because of advancements in healthcare systems and the availability of and the need for sophisticated surgical procedures, such as cardiovascular & transplant surgery, trauma care, and therapy for cancer and blood diseases. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the market. The global Blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4%.  Download PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Market Segmentation: - The blood screening market is segmented into reagents & kits, instruments, and software & services. The reagents & kits accounted for the largest share of the market in 2020, mainly due to repeated use of reagents & kits in blood screening procedures due to the rising blood transfusion procedures, and the high consumption. The blood screening market is segmented into nucleic acid test (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). In 2020, the nucleic acid test (NAT) segment accounted for the largest share of the market. Factors such as the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies and increasing number of blood donations. Based on end users, the blood screening market is segmented into blood banks and hospitals. In 2020, the blood banks segment accounted for the largest share of the market. The growing number of organ transplantation surgeries is driving the growth of this segment, and the increasing demand for donated blood. Regional Analysis: The global market is segmented into five major regions—north America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the market. The North American market growth can be attributed to the increasing healthcare spending, increasing prevalence of chronic disorders, and the highly developed healthcare system in the US and Canada. REQUEST FOR CUSTOMIZATION :- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=267747042 Top key Players: - The major players operating in this blood screening market are Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US), bioMérieux (France), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), Beckman Coulter, Inc. (Danaher) (US), DiaSorin (Italy), Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. (US), Ortho Clinical Diagnostics Inc. (US), GE Healthcare (US), Merck KGaA (Germany), PerkinElmer (US), Bio-Techne Corporation (US), GFE (Germany), Trinity Biotech (Ireland), Mindray (China), Maccura Biotechnology Co., Ltd. (China), Immucor, Inc. (US), Cellabs (Australia), Abnova Corporation (Taiwan), Enzo Biochem, Inc. (US), and Cepheid (US).

Increasing research activities in the field of nanotechnology, increasing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries fueling the growth of the market. Moreover, increasing government support for nanotechnology research and rapidly growing pharmaceutical industry in emerging countries, are some of the other major factors driving the growth of particle size analysis market. The global Particle size analysis market size is projected to reach USD 492 million by 2026 from USD 371 million in 2021, growing at a CAGR of 5.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833   Scope of the Report: This research report categorizes the particle size analysis market based on technology and region. By Technology Laser Diffraction Dynamic Light Scattering Imaging Dynamic Imaging Static Imaging Nanoparticle Tracking Analysis (NTA) Coulter Principle Sieve analysis Other Technologies* Note: *Other technologies include resonant mass measurement, laser obscuration, and sedimentation technologies. By Dispersion Type Wet Dispersion Dry Dispersion Spray Dispersion By End-use Industry Healthcare Industry Pharmaceutical & Biotechnology Companies Public & Private Institutions Academic Institutions Cosmetic Industry Chemicals & Petroleum Industry Mining, Minerals and Cement Industry Food & Beverage Industry Other Industries * Note:*Other industries include industries related to inks, toners, paints, coatings, and environmental analysis By Region North America US Canada Europe Germany France UK Italy Spain RoE Asia Pacific Japan China India Australia South Korea RoAPAC Latin America Brazil Mexico RoLA Middle East & Africa Market Segmentation: Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, sieve analysis and other technologies. The laser diffraction segment accounted for the largest share of this market in 2020, driven by growing initiatives to create awareness about laser diffraction, increasing trainings conducted by companies, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns. Based on type, the imaging market is segmented into two major types—dynamic imaging, and static imaging. Factors such as high-quality/resolution images, better image recognition, user friendliness, individual sample measurement, and high speed analysis are driving the growth of the dynamic imaging segment. The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth over the forecast among the particle size analysis technologies market over the forecast period. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology. In addition, NTA is mainly used in biopharma and biotech applications and with increasing R&D activities in the biopharmaceutical industry, this market segment is expected to show growth during the forecast period. Regional Analysis: - The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of this market in 2020. Presence of a large customer base in the region, relatively low energy prices in the US market as compared to other competitive nations such as the UK and Japan are encouraging the growth of end-use markets (such as mining, minerals, chemicals, petroleum) in the US. Moreover, significant funding for nanotechnology development and strict industrial regulations for particle size analysis for pharmaceutical drugs and food products with respect to drug development and quality control are some of the major factors driving the growth of the life science instrumentation sector in North America. Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833 Top Key Players:- The major players operating in the global particle size analysis market include Malvern Panalytical Ltd. (UK), HORIBA (Japan), Beckman Coulter, Inc. (US), Anton Paar GmbH (Austria), Aimsizer (China), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), METLLER TOLEDO (US), Micromeritics Instrument Corporation (US), Microtrac Retsch GmbH (Germany), Shimadzu Corporation (Japan), Sympatec GmbH (Germany), and TSI (US), among others.

The growth of laboratory proficiency testing market is primarily driven by factors such as it forms an essential precondition for operational excellence and accreditation in several industries. Also, the increasing number of laboratory accreditations, stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth. However, the requirement of high capital investments for accurate and sensitive testing is expected to restrain the growth of this market during the forecast period. The growth of the pharmaceutical proficiency testing market is driven by Stringent quality control in the production of pharmaceutical products, Growth of the pharmaceuticals market, Surge in the generics market, and Emerging biosimilars market while the major restraining factor is Cost and time-intensive drug manufacturing process. The global laboratory proficiency testing market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.4%.  Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949 Market Segmentation: Based on industry, the laboratory proficiency testing market is segmented into clinical diagnostics, food & animal feed, pharmaceuticals, microbiology, environmental, water, biologics, commercial beverages, cannabis/opioids, cosmetics, dietary supplements, and nutraceuticals. In 2020, the clinical diagnostics segment accounted for the largest share of the market. The large share of this segment is attributed to the development of complex diagnostic tests and the need for early diagnosis, which makes quality management with the use of proficiency testing an essential aspect of clinical diagnostics. Based on technology, the global laboratory proficiency testing market has been segmented into spectrophotometry, chromatography, PCR, immunoassays, cell culture, and other technologies. The cell culture segment accounted for the largest share of the market in 2020. Growing awareness regarding the use of cell cultures in the production and testing of various clinical diagnostics samples, microbiology samples, and biopharmaceuticals is supporting the growth of this market. Regional Analysis: The laboratory proficiency testing market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share in the market. The large share of this region can be attributed to the mandatory adoption of laboratory proficiency testing to demonstrate operational excellence, increasing regulatory stringency regarding laboratory operations. The emerging markets across the Asia Pacific and Latin America are expected to grow at higher CAGRs during the forecast period. With significant growth in outsourcing services in the past few years, China and India have emerged as high-growth markets for laboratory proficiency testing. South Korea is another growing market in the APAC region. Other than these APAC countries, Latin American countries also show significant growth potential for the market. REQUEST FOR CUSTOMIZATION: -https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144227949 Top Key Players :- The prominent players in the laboratory proficiency testing market are LGC Limited (UK), American Proficiency Institute (US), College of American Pathologists (US), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), Fapas (Fera Science Ltd.) (UK), Waters Corporation (US), Weqas (UK), AOAC INTERNATIONAL (US), BIPEA (France), NSI Lab Solutions (US), Absolute Solutions (US), Trilogy Analytical Laboratories (US), Advanced Analytical Solutions (US), American Industrial Hygiene Association (US), Matrix Sciences (US), Aashvi Proficiency Testing & Analytical Services (India), and Global Proficiency (New Zealand).

The report "Ophthalmic Equipment Market by Product (Spectacles, Contact Lenses, OCT Scanner, Fundus Camera, Ultrasound,Perimeter,Autorefracter, Slit Lamp, Keratometer, Tonometer, Ophthalmoscope, IOL,OVDs), End User (Consumer, Hospitals) - Global Forecast to 2027", is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%. Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364 The vision care products segment accounted for the largest share of the ophthalmic equipment market, by product in 2021 Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses. “Consumer hold the largest share in the ophthalmic equipment market, by end user in 2021” Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers. North America accounted for the largest share of the ophthalmic equipment market in 2021 In 2021, North America accounted for the largest share the ophthalmic equipment market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country. REQUEST FOR 10% CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364 The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).  

The growth of Microtome market is majorly driven by rising prevalence of cancer, growing demand for digital pathology, recommendations for cancer screening, availability of reimbursement. However, Lack of skilled professionals, and availability of refurbished products are some of the challenges for which may hinder the growth of Microtome market. The global Microtome Market is expected to reach USD 585 million by 2027 from USD 425 million in 2022, at a CAGR of 6.6% during the forecast period. Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411 Market Segmentation: Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market. Regional Analysis: Based on the North America region, the microtome market is devided into US and cananda. US is expected to dominate the microtome market. The high prevalence of cancer, coupled with the increasing demand for the early and effective diagnosis and treatment of cancer, is the key factor driving market growth in the US. Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=230495411 Top Key Players: The major players in the microtome market are Danaher Corporation (US), PHC holdings corporation (Japan), Cardinal Health (US), Boeckeler Instruments, Inc (US), SM Scientific Instruments Pvt. Ltd. (India), Bright Instruments (UK), Sakura Finetek USA, Inc (US), Jinhua Yidi Medical Equipment Co., Ltd (China), Ted Pella, Inc (US), Medimeas (India), SLEE medical GmbH (Germany), Histo-Line Laboratories (Italy), microTec Laborgeräte GmbH (Germany), MEDITE Medical GmbH (Germany), Erma Inc. (Japan)  

The growth of the global Hollow Fiber Filtration Market is driven by factors such as the rising preference for continuous manufacturing, increasing use of single use technologies, and the rising biopharmaceutical industry. In addition, emerging economies, and increased investment cell-based research are expected to provide significant growth opportunities for players in the market. The global Hollow fiber filtration market is projected to reach USD 597 million by 2026 from USD 303 million in 2021, at a CAGR of 14.5% during the forecast period. Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267011039 Market Segmentation: Based on material, the market is segmented into polymeric and ceramic. The polymeric segment is further sub segmented into PS/PES, Polyvinylidene fluoride (PVDF), and Other polymeric materials. In 2020, PS/PES membrane filters accounted for the largest market share as they are designed to eliminate particulates during standard filtration. They have low protein and drug binding characteristics and are stable at alkaline pH. PS/PES membranes are recommended for aqueous applications and for biological samples. These membranes offer high product recoveries due to characteristics such as low affinity and adsorption. In biopharmaceutical industries, PS/PES membranes are mostly used for ultrafiltration in downstream processing, product concentration, and the filtration of biological and pharmaceutical solutions. Based on application type, the market is segmented into continuous cell perfusion, harvest and clarification, and concentration and diafiltration. In 2020, continuous cell perfusion accounted for the largest market share due to the advantages of hollow fibers in continuous cell perfusion, such as enabling efficient cell separation (with low shear) and allowing robust large-scale manufacturing. Regional Analysis: The Asia Pacific market is projected to witness the highest growth rate during the forecast period, primarily due to innovation, a giant talent pool of scientists, low labor, and manufacturing costs. The region has also witnessed mass production because of technology and a rise in continuous manufacturing instead of batch production in the previous era. Asia Pacific region is also a lucrative market for foreign investors, with key market players having their presence in the region. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small and medium-scale CMOs set up in APAC have obtained US FDA approval for their operations and completed GMP certifications, thus driving the regions market. Request for Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=267011039 Top Key Players: Prominent players in the Hollow Fiber Filtration Market are Repligen Corporation (US), Danaher (US), Asahi Kasei Corporation (Japan), Parker-Hannifin Corp (US), Sartorius Stedim Biotech S.A (France), TOYOBO CO., LTD (Japan), and Cantel Medical (US). The key players in this market are focusing on strategic expansions, and acquisition to expand their presence in the market.

The use of cloud-based patient registry solutions helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease. In addition, these solutions do not require any upfront capital investment for hardware and provide faster data transfer between organizations. Considering these advantages, the preference for cloud-based patient registry solutions is expected to increase among end users during the forecast period. The global Patient registry software market is projected to reach USD 2.8 billion by 2026 from USD 1.4 billion in 2021, at a CAGR of 15.0% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594  ; Scope of the Report The study categorizes the patient registry software market based on types of registry, types of software, pricing model, deployment model, types of database, functionality, end user and regional and global level. Global Patient Registry Software Market, by Types of Registry Patient Registry Software Market, By Type of Registry  Introduction  Disease Registry Diabetes Registries Cardiovascular Registries   Cancer Registries   Rare Disease Registries   Asthma Registries   Chronic Kidney Registries   Orthopedic Registries   Other Disease Registries  Health Service Registeries  Product Registeries   Medical Device Registries   Drug  Registries Patient Registry Software Market, By Type of Software Patient Registry Software Market, By Type of Software  Introduction  Integrated Software Patient Registry Software Market, By Pricing Model Patient Registry Software Market, By Pricing Model  Introduction  Subscription Model;  Ownership Model Patient Registry Software Market, By Deployment Model Patient Registry Software Market, By Deployment Model  Introduction  On-Premise Model  Cloud-Based Model Patient Registry Software Market, By Type of Database Patient Registry Software Market, By Type of Database  Introduction  Commercial Database  Public Database Patient Registry Software Market, By Functionality Patient Registry Software Market, By Functionality  Introduction  Population Health Management  Patient Care Management  Medical Research & Clinical Studies  Health Information Exchange  Point-of-Care  Product Outcome Evaluation Patient Registry Software Market, By End User Patient Registry Software Market, By End User  Introduction  Government Organizations and Third-Party Administrators.  Hospitals & Medical Practices  Private Payers  Pharmaceutical, Biotechnology, and Medical Device Companies  Research Centers Global Patient Registry Software Market, by Region North America US Canada Europe Uk Germany France Italy Spain Rest Of Europe Asia Pacific Japan China India Rest of APAC Latin America Middle East & Africa Market Segmentation: On the basis of type of registry, the disease registries segment accounted for the largest share of the patient registry software market in 2020. The large share of this segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe. Based on end user, the hospitals & medical practices segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are growing prevalence of research, QM and improvement, facility planning and marketing, and monitoring patient outcomes. Regional Analysis: North America accounted for the largest share of the market in 2020, followed by Europe and Asia Pacific. The increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, increasing adoption of HCIT as a cost-containment measure are some of the factors driving the growth of the market in North America. Inquiry Before Buying : https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144694594 Top Key Players: Some of the prominent players in this patient registry software market are IBM Corporation (US), IQVIA Holdings (US), OpenText Corporation (Canada), Optum (US), Premier, Inc. (US), ArborMetrix, Inc. (US), FIGmd (US), McKesson Corporation (US), Syneos Health (US), Dacima Software, Inc. (Canada), ifa Systems AG (Germany), Medstreaming- M2S (US), ImageTrend, Inc. (US), Evado Clinical (Australia), WIRB Copernicus Group (US), Global Vision Technologies, Inc. (India), Conduent, Inc. (US), Elekta AB (Sweden), Cedaron (US), LUMEDX (US), Armus Corp (US), Phamax AG (Switzerland), and Versaform Systems Corp (US), ESO Solutions (US) and Ordinal Data, Inc. (US).  

The growth of the North American radiation protection aprons market is being driven by factors such as increasing number of trained radiologic technologists, increasing safety awareness, the growing number of orthopedic and spine surgeries, and growth in the number of PET/CT scans. The North American radiation protection aprons market is projected to reach USD 48 million by 2026 from USD 35 million in 2021, at a CAGR of 6.9% during the forecast period.  Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124332526 Market Segmentation: Based on type, the North American radiation protection aprons market is segmented into front protection aprons, vest & skirt aprons, and other aprons. In 2020, the front protection aprons segment accounted for the largest share of this market primarily due to the wide availability and high usage of these aprons in dental clinics and hospital settings. Regional Analysis: - Based on country, the North American radiation protection apron market is segmented into the US and Canada. The growth of the North American market can be attributed to increasing awareness of radiation safety, the increasing number of radiography procedures performed, and ongoing research aimed at the development of new and advanced radiation protection products. In 2020, the US accounted for the largest share of the radiation protection aprons market. The large share can be attributed to the increasing number of radiography procedures performed and the rising number of healthcare professionals that use radiography equipment. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=124332526   Top key Players :-  The major players operating in the North American radiation protection aprons market include Infab Corporation (US), Bar-Ray Products (US), AliMed, Inc. (US), Burlington Medical (US), Shielding International, Inc. (US), Protech Medical (US), AADCO Medical, Inc. (US), Lite Tech (US), Barrier Technologies (US), and BLOXR Solutions (US).